InVivo Therapeutics Holdings Corp. announced the resignation of Steven McAllister from the position of Chief Financial Officer effective December 31, 2016. He has indicated he will be transitioning to a new opportunity at a privately-held medical device company.

In connection with his departure, the company has appointed Melanie Morel-Ferris to assume the responsibilities and title of interim Chief Financial Officer, effective January 1, 2016. In this capacity, she will serve the role of the Company's Principal Financial Officer and Principal Accounting Officer. Morel-Ferris has served as the company's Controller since May, 2016.

Prior to joining the company, Morel-Ferris served as the Corporate Controller of Astrodyne TDI.